Figure 2From: Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Electropherogram from Sanger dideoxy sequencing showing the patient's melanoma tumor BRAF codon 600 mutation (AAG/GTG), encoding V600K/WT protein.Back to article page